We describe inflammatory vaginitis as a potential side effect of long-term rituximab treatment for multiple sclerosis in the absence of any other systemic disease or underlying malignancy. More studies are… Click to show full abstract
We describe inflammatory vaginitis as a potential side effect of long-term rituximab treatment for multiple sclerosis in the absence of any other systemic disease or underlying malignancy. More studies are needed to characterise the incidence of inflammatory vaginitis among women on long-term rituximab therapy.
Keywords:
long term;
inflammatory vaginitis;
term rituximab
Journal Title: BMJ Case Reports
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: BMJ Case Reports
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!